Paddington Life Sciences improves health and reduces inequalities by connecting communities, researchers and industry, centered around St Mary's Hospital, to bring health innovation to life.
OUR VISION
In parallel with the redevelopment of the St Mary’s Hospital site we have an opportunity to bring together industry, academia, the NHS and local communities for the creation of a new clinical life sciences cluster in Paddington, driving improved health, wealth and well-being.
Our partners
.png?rev=afb863a06b7c4d25a2e5abb6e55af12a&h=80&w=250&la=en&hash=3529B8F6BDE709224BB2B2573FC8327B){kind=logo}
OUR DIFFERENCE
Spanning three million square feet alongside the Grand Union Canal in Paddington, the redeveloped St Mary’s site will create a new kind of healthcare and life sciences complex. This will include the hospital and up to an additional 1.5 million square feet of flexible, cross-functional commercial and lab space for life sciences businesses to start, develop or grow.
The opportunity for commercial and academic teams to co-locate within new specialist life sciences facilities will accelerate bringing new treatments to patients as well as giving every patient the chance to take part in clinical research trials for local, national, and global benefit.
News
-
Read the full storyTrust patient is first participant in Europe to join study of new treatment for rare bleeding disorder
The trial will test a new treatment for people who have a rare autoimmune bleeding condition known as immune thrombocytopenic purpura.
-
Read the full storyNHS graduate trainees explore innovation and leadership through Paddington Life Sciences
Future NHS leaders gain insights into data-driven transformation through Paddington Life Sciences and Imperial College London.
-
Read the full storyAdvancing clinical trials
A report co-authored by Paddington Life Sciences, the Faculty of Pharmaceutical Medicine, and Egality Health on exploring strategies to make the UK a global leader in inclusive clinical trials.